Haemodynamic effects of losartan an angiotensin II receptor antagonist in patients with cirrhosis and portal hypertension.

被引：0
|
作者：
Tripathi, D [1 ]
Therapondos, G [1 ]
Lui, HF [1 ]
Hayes, PC [1 ]
机构：
[1] Royal Edinburgh Infirm, Liver Unit, Edinburgh, Midlothian, Scotland
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1470
引用
收藏
页码：527A / 527A
页数：1
相关论文
共 50 条
  • [41] Effects of hyperinsulinemia and angiotensin II receptor blockage on plasma endothelin-1 in patients with hypertension.
    Seljeflot, I
    Moan, A
    Tonnessen, T
    Kjeldsen, SE
    Arnesen, H
    CIRCULATION, 1996, 94 (08) : 1988 - 1988
  • [42] Angiotensin1 receptor antagonist losartan.: Part II.: Effects arterial hypertension and diabetic nephropathy
    Sidorenko, BA
    Preobrazhensky, DV
    Stetsenko, TM
    Tarykina, EV
    Tsurko, VV
    KARDIOLOGIYA, 2003, 43 (02) : 88 - 95
  • [43] Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study
    Merkel, C
    Schipilliti, M
    Bighin, R
    Bellini, B
    Angeli, P
    Bolognesi, M
    Vescovi, F
    Gatta, A
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (04) : 269 - 274
  • [44] Long-term effects of angiotensin II receptor antagonist, losartan on platelet responsiveness to mental stress in essential hypertension
    Koike, Tsutomu
    Tomoda, Fimihiro
    Kinuno, Hiroyuki
    Sugimori, Hiroko
    Kagitani, Satoshi
    Yasumoto, Kotaro
    Inoue, Hiroshi
    JOURNAL OF HYPERTENSION, 2006, 24 : 261 - 261
  • [45] Effects of angiotensin II and the AT1 receptor antagonist losartan on the renal excretion of urodilatin
    Heringlake, M
    Bahlmann, L
    Klaus, S
    Wagner, K
    Schmucker, P
    Pagel, H
    KIDNEY & BLOOD PRESSURE RESEARCH, 2001, 24 (02): : 79 - 83
  • [46] Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations
    Baudin, B
    PHARMACOGENOMICS, 2002, 3 (01) : 65 - 73
  • [47] Angiotensin II receptor antagonists and portal hypertension
    Lebrec, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (03): : 254 - 255
  • [48] BIOCHEMICAL EFFECTS OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
    GOLDBERG, MR
    BRADSTREET, TE
    MCWILLIAMS, EJ
    TANAKA, WK
    LIPERT, S
    BJORNSSON, TD
    WALDMAN, SA
    OSBORNE, B
    PIVADORI, L
    LEWIS, G
    BLUM, R
    HERMAN, T
    ABRAHAM, PA
    HALSTENSON, CN
    LO, MW
    LU, H
    SPECTOR, R
    HYPERTENSION, 1995, 25 (01) : 37 - 46
  • [49] Does angiotensin II receptor antagonist Losartan suppress drinking behavior in hemodialysis patients?
    Shimada, N
    Hayashi, K
    Saka, S
    Nakamura, T
    Ebihara, I
    Koide, H
    RENAL FAILURE, 2001, 23 (05) : 753 - 755
  • [50] Beneficial hemodynamic effects of bosentan, an ET(A) and ET(B) receptor antagonist of endothelin in portal hypertension.
    Lebrec, D
    Cailmail, S
    Moreau, R
    Gadano, A
    Clozel, M
    HEPATOLOGY, 1996, 24 (04) : 759 - 759
12345